Hesperos

United States
Orlando, Florida, United States, 32826

Company profile

Hesperos company profile

Hesperos, Inc. is a leader in efforts to characterize an individual's biology with Human-on-a-Chip microfluidic systems. Founders Michael L. Shuler and James J. Hickman have been at the forefront of every major scientific discovery in this realm, from individual organ-on-a-chip constructs to fully functional, interconnected multi-organ systems. With a mission to revolutionize toxicology testing as well as efficacy evaluation for drug discovery, the company has created pumpless platforms with serum-free cellular mediums that allow multi-organ system communication and integrated computational PKPD modeling of live physiological responses utilizing functional readouts from neurons, cardiac, muscle, barrier tissues and neuromuscular junctions as well as responses from liver, pancreas and barrier tissues.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01

Headquarters

Postal code
32826
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
4
Last funding
Grant / $2M / 2024-05-07
Investors
2
Lead investors
2
Founders
2
Articles
18

Founders and investors

Founders

James "J." HickmanMichael L. Shuler

Lead investors

National Institutes of HealthNCATS

Investors

National Institutes of HealthNCATS